CDC Clinical Guidelines on the Use of Doxycycline Postexposure Prophylaxis for Bacterial Sexually Transmitted Infection Prevention, United States, 2024

Laura H. Bachmann(Centers for Disease Control and Prevention), Leandro Mena(Emory University), Philip A. Chan(John Brown University), Lindley A. Barbee, Jonathan Mermin(National Center for HIV/AIDS Viral Hepatitis STD and TB Prevention), Kimberly Workowski(Emory University), Karen L. Hoover, Hilary Reno
MMWR Recommendations and Reports
June 4, 2024
10.15585/mmwr.rr7302a1
Cited by 206

Related Papers

Sexually Transmitted Infections Treatment Guidelines, 2021
|MMWR Recommendations and Reports|2021|2.5k
Assessing differential impacts of COVID-19 on black communities
|Annals of Epidemiology|2020|1.2k
Hepatitis C Guidance 2018 Update: AASLD-IDSA Recommendations for Testing, Managing, and Treating Hepatitis C Virus Infection
|Clinical Infectious Diseases|2018|726
Stigma, medical mistrust, and perceived racism may affect PrEP awareness and uptake in black compared to white gay and bisexual men in Jackson, Mississippi and Boston, Massachusetts
|AIDS Care|2017|405
Risk for COVID-19 infection and death among Latinos in the United States: examining heterogeneity in transmission dynamics
|Annals of Epidemiology|2020|361